Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Trends in Cancer Research   Volumes    Volume 10 
Neoadjuvant therapy in pancreatic cancer: the emerging standard of care
Lindsay L. Hollander, Xiaojia Guo, Ronald R. Salem, Charles H. Cha
Pages: 27 - 44
Number of pages: 18
Trends in Cancer Research
Volume 10 

Copyright © 2014 Research Trends. All rights reserved

Pancreatic adenocarcinoma is a rapidly lethal disease process for which, surgical resection is currently the only potential curative treatment. In order to maximize the number of patients able to undergo resection and to maximize the outcome of the procedure itself, extensive research has been completed on potential neoadjuvant therapies for pancreatic cancer. Several sources have confirmed that neoadjuvant therapy can improve the oncologic quality of resection in borderline pancreatic cancer patients and even potentially convert those with locally advanced disease. This article reviews the pros and cons of neoadjuvant therapy in pancreatic cancer, the definitions of resectable, borderline resectable, and locally advanced pancreatic cancer, and the significant studies and current recommendations for the use of neoadjuvant treatment with radiation, chemotherapy, chemoradiation, and/or targeted therapies.
View Full Article  


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms